SP 05
Treatment of relapsed, refractory multiple myeloma: focus on new drugs
Angelo Maiolino
Lido
3401
Vezesque se leu este artigo
1255
Total PDF
2146
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 23 | 6 | 29 |
| 2025 5 | 51 | 13 | 64 |
| 2025 4 | 46 | 14 | 60 |
| 2025 3 | 46 | 8 | 54 |
| 2025 2 | 44 | 25 | 69 |
| 2025 1 | 35 | 15 | 50 |
| 2024 12 | 27 | 15 | 42 |
| 2024 11 | 49 | 19 | 68 |
| 2024 10 | 40 | 17 | 57 |
| 2024 9 | 50 | 24 | 74 |
| 2024 8 | 41 | 31 | 72 |
| 2024 7 | 34 | 21 | 55 |
| 2024 6 | 44 | 31 | 75 |
| 2024 5 | 42 | 27 | 69 |
| 2024 4 | 83 | 17 | 100 |
| 2024 3 | 93 | 22 | 115 |
| 2024 2 | 74 | 25 | 99 |
| 2024 1 | 66 | 22 | 88 |
| 2023 12 | 45 | 20 | 65 |
| 2023 11 | 53 | 40 | 93 |
| 2023 10 | 35 | 28 | 63 |
| 2023 9 | 59 | 34 | 93 |
| 2023 8 | 18 | 13 | 31 |
| 2023 7 | 35 | 12 | 47 |
| 2023 6 | 33 | 20 | 53 |
| 2023 5 | 39 | 15 | 54 |
| 2023 4 | 19 | 18 | 37 |
| 2023 3 | 45 | 12 | 57 |
| 2023 2 | 32 | 9 | 41 |
| 2023 1 | 30 | 13 | 43 |
| 2022 12 | 37 | 15 | 52 |
| 2022 11 | 41 | 19 | 60 |
| 2022 10 | 67 | 29 | 96 |
| 2022 9 | 41 | 27 | 68 |
| 2022 8 | 21 | 22 | 43 |
| 2022 7 | 25 | 27 | 52 |
| 2022 6 | 22 | 24 | 46 |
| 2022 5 | 26 | 22 | 48 |
| 2022 4 | 57 | 19 | 76 |
| 2022 3 | 37 | 25 | 62 |
| 2022 2 | 42 | 27 | 69 |
| 2021 1 | 26 | 34 | 60 |
| 2021 12 | 24 | 35 | 59 |
| 2021 11 | 29 | 25 | 54 |
| 2021 10 | 33 | 27 | 60 |
| 2021 9 | 23 | 23 | 46 |
| 2021 8 | 22 | 41 | 63 |
| 2021 7 | 24 | 31 | 55 |
| 2021 6 | 19 | 31 | 50 |
| 2021 5 | 32 | 31 | 63 |
| 2021 4 | 52 | 28 | 80 |
| 2021 3 | 35 | 26 | 61 |
| 2021 2 | 24 | 22 | 46 |
| 2020 1 | 19 | 13 | 32 |
| 2020 12 | 17 | 24 | 41 |
| 2020 11 | 20 | 22 | 42 |
Mostrar tudo
